Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €61.92 EUR
Change Today +1.39 / 2.29%
Volume 77.0K
MOR On Other Exchanges
As of 3:35 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Walter A. Blattler Ph.D.

AgeTotal Calculated CompensationThis person is connected to 5 board members in 1 different organizations across 4 different industries.

See Board Relationships


Dr. Walter A. Blattler, Ph.D., serves as Chief Advisor of R&D and Director at Formation Biologics Inc. Dr. Blattler serves as Vice President of Manufacturing at Semma Therapeutics, Inc. He served as an Executive Vice President of Science and Technology at ImmunoGen, Inc. since 1996. Prior to joining ImmunoGen at its newly established laboratories, Dr. Blattler held various positions at the Dana-Farber Cancer Institute, Harvard Medical School, in Boston. In 1987 he joined ...

Read Full Background

Corporate Headquarters*

Lena-Christ-Strasse 48
Martinsried, Bavaria 82152


Phone: 49 8989 9270
Fax: 49 89 8992 7222

Board Members Memberships*

Chief Advisor of R&D and Director


Unknown/Other Education
Eidgenössische Technische Hochschule Zürich
MS 1973
Eidgenössische Technische Hochschule Zürich
PhD 1978
Eidgenössische Technische Hochschule Zürich
Post-Doctoral Training
Harvard University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MOR:GR €61.92 EUR +1.39


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MORPHOSYS AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at